Mephameson

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Mephameson

Property Description
Active Ingredient Dexamethasone
Form Tablet, Solution (Injectable/Oral), Cream, Drops
Pharmacological Class Corticosteroid / Glucocorticoid
General Purpose Controlling inflammation and immune suppression
Origin Synthetic adrenocortical steroid

Mephameson is a potent, prescription-only medication whose active compound is Dexamethasone, which is chemically defined as a synthetic adrenocortical steroid. It belongs to the glucocorticoid pharmacological class, a group of medicines vital for modulating the body’s inflammatory and immune responses. This drug is manufactured to possess a powerful, long-acting effect, which provides sustained potency compared to shorter-acting natural adrenal hormones.


Identity and General Classification

Mephameson is classified as a highly effective glucocorticoid, a type of corticosteroid essential for regulating systemic inflammation. Dexamethasone is used to treat a variety of conditions, supporting its status as a powerful anti-inflammatory and immunosuppressant agent. The differentiation point for Dexamethasone is its high potency and specific long duration of action in the body, making it valuable for conditions requiring sustained pharmacological control. Furthermore, it is considered a fluorinated glucocorticoid, a subtype engineered to enhance its anti-inflammatory effects while having minimal impact on fluid and salt balance.


Composition and Purpose

The basis of Mephameson is its single active ingredient, Dexamethasone, supplied through various dosage forms including oral tablets, injectable solutions, and topical creams. This wide range of available forms is a key differentiating factor, allowing medical use across multiple routes of administration (oral, parenteral, topical). Its general purpose is to provide relief from intense, widespread inflammatory symptoms and to modulate immune-related disorders. This potent systemic action is designed to control conditions where the body's natural defense mechanisms are causing excessive or disruptive symptoms, such as severe allergic reactions or autoimmune flare-ups.

What side effects are possible with Mephameson?

Mephameson (which contains the active ingredient Dexamethasone, a corticosteroid) can cause a range of side effects, which are generally more likely with higher doses or prolonged use. You should always discuss potential risks and benefits with your healthcare provider.

Common Side Effects

Commonly reported side effects include insomnia (difficulty sleeping), increased appetite leading to potential weight gain, and gastrointestinal issues such as indigestion, nausea, and stomach irritation. Taking the medication with food can often help minimize stomach upset. Other common effects may include mood changes (e.g., anxiety, restlessness), and fluid retention, which can cause swelling.

Important Safety Information and Serious Side Effects

Mephameson can suppress the immune system, making you more vulnerable to infections and potentially masking their symptoms. Avoid exposure to people with contagious illnesses like chickenpox or measles if you are not immune, and report any signs of infection (such as fever or persistent sore throat) to your doctor immediately.

Long-term use can affect the endocrine system and may lead to serious conditions, including suppression of the adrenal gland (adrenal insufficiency) or Cushing's syndrome (symptoms may include a rounded face, weight gain in the upper back and abdomen, and high blood sugar). Discontinuing the drug abruptly, especially after long-term use, can be dangerous and must be done under a doctor’s supervision.

Other potential serious long-term effects include:

  • Ocular conditions: Development of cataracts or glaucoma.
  • Cardiovascular issues: High blood pressure.
  • Musculoskeletal issues: Osteoporosis (weakening of bones) and muscle weakness.
  • Pediatric patients: Long-term use in children can cause slowed growth and bone development issues.

Seek immediate medical attention if you experience signs of a severe allergic reaction (e.g., swelling of the face, lips, tongue, or throat; trouble breathing), severe abdominal pain, black or tarry stools, or vision problems.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation for Mephameson (Dexamethasone) states that acute overdose is typically associated with low acute toxicity, generally presenting with transient gastrointestinal symptoms such as nausea, vomiting, or abdominal pain.


Documented Manifestations and Serious Outcomes

The primary concern is chronic overexposure or prolonged high-dose use, which can lead to severe systemic effects due to the potent glucocorticoid action. These officially documented manifestations include:

  • Systemic Effects: Development of Cushingoid features, Hypertension (high blood pressure), and significant fluid and electrolyte disturbances, such as Hyperglycemia (high blood sugar) and Hypokalemia (low potassium).
  • Severe Complications: The risk of HPA axis suppression (Hypothalamic-Pituitary-Adrenal axis) is documented with chronic high-dose use, requiring careful medical management. Convulsions and psychiatric disturbances are also noted.

Emergency Actions and Supportive Treatment

Official regulatory labeling dictates that no specific antidote is known for Dexamethasone overdose. Consequently, management is strictly symptomatic and supportive, aiming to correct any physiological imbalances that occur.

The regulatory guidance advises individuals to seek immediate medical attention or contact a Poison Control center for any suspected overdose. Close clinical monitoring of fluid balance, electrolyte levels, and blood glucose is required due to the drug's metabolic effects.

Therapeutic Uses of Mephameson

What Mephameson Treats: Main Uses and Benefits

Mephameson provides supportive relief and stabilizing support across various severe inflammatory and immune-driven conditions. The medication is generally used to help with inflammation, severe allergies, and symptoms of autoimmune conditions, among other uses.

This medicine is applied across domains where additional symptomatic support is needed and involves heightened systemic burden, such as managing acute allergic reactions, addressing symptoms that become more disruptive during severe rheumatoid arthritis or Lupus flare-ups, used to address symptoms linked to organ-specific functional stress in cerebral edema, and contributing to supportive care for certain blood cancers. It is also relevant when short-term symptomatic assistance is needed for acute respiratory crises or specific endocrine deficiencies.

When symptoms create noticeable interference with daily stability, Mephameson generally helps to moderate the most distressing manifestations, and may help improve day-to-day comfort during periods of heightened symptoms.


Quick Fact: Relief for Acute Swelling
Mephameson is commonly used when symptoms like widespread swelling and airway constriction appear suddenly, as it helps address these clusters of symptoms that may become intense or disruptive.

Regulatory References

  1. NIH MedlinePlus overview of Dexamethasone

Eligibility and Restrictions for Use

Eligibility Profile: Official Regulatory Information (Dexamethasone)

This section outlines the populations and conditions explicitly defined in government regulatory documents (e.g., FDA, EMA) as contraindications or restrictions for the use of systemic dexamethasone, the medicine associated with the trade name Mephameson.

Who Must Not Use This Medicine (Contraindications)

  • Hypersensitivity to the active substance or any excipients.
  • Systemic fungal infections.
  • Active viral diseases, including herpes simplex, viral hepatitis, shingles, and varicella (chickenpox).
  • Receiving live vaccines while taking immunosuppressive doses.
  • Uncontrolled psychoses.

Populations Requiring Special Caution

Population / Condition Eligibility Rule
Older Adults (Geriatric) Close supervision is required due to increased risk of serious consequences from common side effects (e.g., osteoporosis, hypertension).
Pediatric Patients Long-term use may cause growth retardation. Early high-dose treatment in preterm neonates is associated with long-term neurodevelopmental adverse events.
Comorbidities Caution and monitoring are necessary for patients with a history of severe affective disorders, glaucoma, or conditions that increase the risk of gastrointestinal complications (e.g., active peptic ulcers, diverticulitis).
Lactation Status Not recommended for use while breastfeeding (as per some regulatory sources).

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define specific drug and substance interactions for Mephameson (Dexamethasone), based on pharmacokinetic changes and pharmacodynamic risks.

Pharmacokinetic and Exposure Modification

Interaction Type Interacting Agents Official Result on Mephameson
Decreased Exposure (Induction) CYP3A4 Inducers (e.g., Phenytoin, Rifampin, Carbamazepine) Increases Dexamethasone clearance, potentially reducing its effect.
Increased Exposure (Inhibition) CYP3A4 Inhibitors (e.g., Ketoconazole, Itraconazole, Voriconazole) Slows Dexamethasone metabolism, increasing its plasma concentration.

Pharmacodynamic and Risk Interactions

Concomitant administration with certain product categories may increase specific physiological risks:

  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Increases the documented risk of gastrointestinal ulceration and hemorrhage.
  • Antidiabetic Agents: Mephameson's effect on glucose metabolism can necessitate adjustments for agents like Insulin or Metformin by reducing their blood sugar-lowering efficacy.
  • Potassium-Depleting Agents: Additive effects with agents such as Diuretics or Amphotericin B increase the risk of hypokalemia.
  • Anticoagulants: The combination may unpredictably alter the anticoagulant effect (e.g., Warfarin).

Formal Regulatory Restrictions

  • Contraindicated Combinations: Mephameson must not be co-administered with Live Vaccines when the corticosteroid is used at immunosuppressive doses. Use is also restricted in the presence of Systemic Fungal Infections.
  • Non-Medicinal Interactions: Consumption of Alcohol may increase the documented risk of gastrointestinal irritation and bleeding.

Mechanism of Action

Glucocorticoid Receptor Activation and Gene Control

The drug’s action begins at the molecular level where it acts as an agonist of the Glucocorticoid Receptor ( GR) within the cell. This receptor binding initiates a genomic cascade where the drug-receptor complex moves to the nucleus to both repress genes that produce pro-inflammatory mediators (like NF-kappa B) and activate genes that direct the synthesis of proteins such as annexin A1.

Suppression of Inflammatory Signaling Pathways

The resulting modulation of gene expression leads to systemic effects, primarily reducing the activity of the Arachidonic Acid Cascade by inhibiting the precursor enzyme PLA2. This action reduces the synthesis of localized inflammatory mediators, such as prostaglandins and leukotrienes, resulting in the modulation of systemic inflammatory activity.

Modulation of Immune Cell Function

This mechanism reduces the functional capacity of key immune cells, including lymphocytes and monocytes, and lowers the circulating levels of various pro-inflammatory cytokines. This action alters the signaling of the body's defensive pathways.

Dosage and Administration Information

Mephameson (Dexamethasone) is administered via multiple official routes depending on the required systemic or localized effect. Approved forms include oral tablets and solutions, which are used for routine systemic treatment, and injectable solutions (Intravenous or Intramuscular) typically reserved for acute, severe medical situations. The systemic dosage is highly variable, but general adult systemic regimens often range from 0.75 mg to 9 mg daily. In critical contexts, such as managing cerebral edema, initial IV doses can be as high as 10 mg, followed by a scheduled maintenance dose, often administered every six hours.

For stable, long-term use, the medicine is commonly scheduled once daily and is instructed to be taken in the morning to align with the body’s circadian rhythm. Pediatric dosing is fundamentally weight-based, often delivered in divided doses throughout the day. A fundamental instruction for use is the required gradual dose reduction (tapering) process for any high-dose or extended course of therapy. This procedural requirement is used to prevent the sudden cessation of the medicine. If an oral dose is missed, standard usage instructions include taking it as soon as remembered; however, if it is almost time for the subsequent dose, the missed dose is skipped (never doubled).

Recent Clinical Evidence

Research Evidence / Overview of Studies for Mephameson

Mephameson (Dexamethasone) has been studied for many conditions related to inflammation and immune activity. The evidence base includes large Randomized Controlled Trials (RCTs) and systematic reviews that compile data from multiple studies. Research provides context but not individual predictions; findings describe group patterns, not personal outcomes.


Evidence for Use in Acute Systemic Inflammation Requiring Respiratory Support

This area of research has focused on critically ill patients experiencing severe systemic inflammation, often requiring oxygen or mechanical ventilation. Large-scale RCTs were evaluated in order to measure patient outcomes, including survival and the need for respiratory support.

Analysis concentrated on the most severely ill, with data for certain groups remaining insufficient (e.g., those who did not require oxygen support). Furthermore, follow-up durations were limited, meaning that long-term effects are not fully established by these acute trials.


Evidence for Use in Postoperative Management

Mephameson was evaluated in the immediate period following surgery, with research exploring outcomes related to physical discomfort and acute changes like nausea. Studies monitored pain intensity scores and the incidence of postoperative nausea and vomiting (PONV).

Evidence quality varies across studies due to surgical and dosing differences. The research is focused on very short-term outcomes (e.g., within 24 hours), and long-term effects are not fully established for this specific application.


Evidence for Traditional Uses and Uncertainties

For peritumoral cerebral edema, the evidence base relies on observational cohort studies and generally suggests a Moderate level of certainty. Research measures radiographic outcomes (swelling volume) and patient neurological status.

Research often consists of non-randomized data, meaning certainty remains low regarding comparisons. A key uncertainty is the determination of appropriate study duration or dosage levels for this purpose. In general, research describes that the results apply only to the populations studied and do not provide individual predictions.

Key Studies & References

  1. Dexamethasone: Drug Information (MedlinePlus/NIH)

Frequently Asked Questions (FAQ)

Common questions about Mephameson (FAQ)


Q: Will taking Mephameson make me feel drowsy or dizzy?

Official product information indicates that dizziness has been reported as a potential side effect of Mephameson (Dexamethasone). Official warnings sometimes advise caution regarding operating machinery or driving if individuals experience side effects such as dizziness or vision changes.

Q: Are there any long-term side effects associated with Mephameson use?

Yes, regulatory warnings state that prolonged use of Mephameson can increase the risk of serious cumulative side effects. These may include the development of osteoporosis (bone weakening), cataracts or glaucoma (eye conditions), high blood pressure, and an endocrine disorder called Cushing's syndrome. These risks are generally related to the duration and dosage of the treatment.

Q: Can Mephameson be taken with herbal supplements like St. John's Wort?

Regulatory documents advise caution regarding substances that can increase the clearance of the drug by inducing the CYP3A4 enzyme, which may reduce Mephameson's effectiveness. The interaction profile suggests that St. John's Wort may reduce the drug's effectiveness, which is why co-administration is typically discouraged in official guidance.

Q: Why do doctors prefer Mephameson over other similar medications sometimes?

Mephameson (Dexamethasone) is classified by regulatory agencies as a highly potent glucocorticoid, a type of steroid, with a notably long duration of action. This pharmacological profile makes it suitable for medical situations that require sustained control over inflammation or immune responses, which is a key distinguishing factor.

Q: Is Mephameson considered a strong medication?

Yes, official regulatory labeling classifies Mephameson (Dexamethasone) as a potent synthetic glucocorticoid. It is known for its strong anti-inflammatory and immunosuppressant effects, distinguishing it as a powerful medication in its class.

Q: What research studies support the effectiveness of Mephameson?

The effectiveness of Mephameson is supported by a large body of clinical research, including systematic reviews and multiple large-scale Randomized Controlled Trials (RCTs). These studies have been essential in evaluating its benefit for conditions involving severe inflammation, especially in critical care settings.

Q: Is there a generic version of Mephameson available?

Yes, the active ingredient in Mephameson is Dexamethasone, which is the official generic name. Generic Dexamethasone is approved and available through various manufacturers.

Q: Is it normal to feel a mild stomach ache when first starting Mephameson?

Gastrointestinal issues, such as stomach irritation and indigestion, are listed in regulatory documents as common side effects. Labeling notes that taking the medication with food is a common practice that may help reduce this kind of stomach discomfort.

Q: Can Mephameson affect my mood or cause anxiety?

Yes, Mephameson may impact your mental state. Regulatory documents list mood changes, anxiety, nervousness, and emotional instability among the reported psychiatric side effects. Significant mood changes, if they occur, are generally advised to be discussed with a healthcare provider.

Q: Can people with high blood pressure take Mephameson?

Official warnings state that patients with a history of high blood pressure (hypertension) require caution and monitoring while taking Mephameson. This is because the drug can potentially contribute to or worsen existing high blood pressure.

Q: Does Mephameson need to be taken with food?

While the requirement may vary by specific dosage form, regulatory advice notes that taking the medication with food is a common practice used to help minimize potential gastrointestinal side effects like stomach irritation.

Q: Can Mephameson be crushed or chewed if I have trouble swallowing pills?

The ability to crush or alter the tablet depends entirely on the specific product formulation. While standard tablets may sometimes be altered, specialized or extended-release forms must be swallowed whole to ensure proper effectiveness and safety. Whether a tablet can be altered is dependent on the specific product formulation and should be confirmed with the prescribing healthcare provider.

Q: Are headaches a common side effect when starting Mephameson?

Yes, headache is listed in official product information as a reported neurological side effect of Mephameson (Dexamethasone). It is listed alongside other common effects such as difficulty sleeping (insomnia) and weight changes.

Q: Will Mephameson show up on a standard drug test?

As a synthetic steroid, Mephameson can interfere with tests that measure the body's natural steroid levels. Specifically, it is known to affect tests like the Dexamethasone Suppression Test, which is used to evaluate the function of the body's natural cortisol production.

Q: Is it safe to drive or operate machinery after taking Mephameson?

Official warnings sometimes advise that caution should be exercised when driving or operating heavy machinery. This is because certain side effects, such as blurred vision or dizziness, which can impair function, have been reported with Mephameson use.

Q: Can Mephameson be used to treat symptoms of a common cold or flu?

Mephameson is primarily used for its strong anti-inflammatory and immune-suppressing effects. The official regulatory indications do not include routine treatment for common viral infections like the cold or flu, and the medication is explicitly contraindicated in the presence of active viral diseases.

Q: How long can a person safely stay on a course of Mephameson?

The appropriate length of therapy is highly individualized and condition-dependent. To minimize the risk of serious complications, especially adrenal suppression, regulatory guidance emphasizes using the lowest effective dose for the shortest possible duration. Any withdrawal from the medicine must be done gradually.

Q: What does the latest research say about Mephameson's use in chronic conditions?

Mephameson is approved for managing a variety of long-term inflammatory and autoimmune disorders. While current research supports its effectiveness, regulatory bodies note that the evidence base for very long-term chronic use requires ongoing monitoring due to the known risks of cumulative side effects.

Q: What is the difference in how Mephameson works compared to NSAIDs?

Mephameson acts at a molecular level by activating the Glucocorticoid Receptor, which broadly regulates inflammatory gene expression. In contrast, non-steroidal anti-inflammatory drugs (NSAIDs) typically work by directly blocking the cyclooxygenase (COX) enzyme, which is a narrower target in the inflammation pathway.

Q: What are some serious but rare side effects of Mephameson I should watch for?

Official safety information directs patients to watch for signs of severe but rare reactions, such as a severe allergic reaction (anaphylaxis), signs of gastrointestinal bleeding or ulcer (severe abdominal pain), and serious infections. These events are considered medical emergencies and require prompt consultation with emergency services or a healthcare provider.

Q: Are there any known interactions between Mephameson and caffeine?

Caffeine is not listed among the primary drug-to-drug interactions (like CYP450 inhibitors) in regulatory documents. However, it can influence the body's natural stress response system, a factor that is considered in specific diagnostic testing protocols involving Dexamethasone.

Q: Is it normal for Mephameson to cause slight changes in appetite?

Yes, official product information lists an increased appetite as a common side effect of Mephameson (Dexamethasone), which can lead to weight gain. Other changes in metabolic function and appetite are also reported.

Q: Can people with heart problems take Mephameson?

Regulatory warnings state that patients with pre-existing heart conditions, such as congestive heart failure or recent heart attack, require careful monitoring. This is because Mephameson can potentially cause fluid retention and high blood pressure, which may worsen these conditions.

Q: Does taking Mephameson require any specific monitoring, like blood tests?

Yes, patients receiving high doses or long-term therapy may require specific monitoring. This includes regular checks for blood pressure, blood sugar levels, and electrolyte balance (especially potassium) due to the drug's known effects on these systems.

Q: How long should I expect Mephameson to start working?

The onset of action depends on the form and purpose of administration. For acute, severe situations where injection is used, the effects can be rapid. For routine oral use, it typically begins working quickly, though the full therapeutic benefit may take longer to notice.

Q: Can pregnant or breastfeeding women use Mephameson?

For breastfeeding, regulatory sources generally state that Mephameson (Dexamethasone) is not recommended. The safety profile for use during pregnancy requires individual risk assessment and is not broadly recommended without specific medical necessity.

Q: How long after stopping Mephameson will the drug be completely out of my system?

Mephameson is known to be a long-acting glucocorticoid. While it is processed by the body, the prolonged duration of its action is why a required gradual dose reduction (tapering) is necessary after extended use to allow the body's natural processes to recover.

How should Mephameson be stored and disposed of?

How to Store and Dispose of Mephameson

Mephameson (Dexamethasone) must be stored according to regulatory requirements to ensure its stability.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Keep in the original container, tightly closed, and protect from light and moisture.
Child Safety Mandatory to keep out of the sight and reach of children.

Disposal Instructions

Unused or expired Mephameson should be discarded using an official drug take-back program when available. If a take-back program is not accessible, follow household disposal guidelines by mixing the medicine with an undesirable substance, sealing it in a bag, and throwing it in the trash. The medication should not be flushed down the toilet or poured into a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Mephameson found in:

A-Z Index: